Cloning and characterization of DULP, a novel ubiquitin-like molecule from human dendritic cells

Chinese Journal of Cellular and Molecular Immunology

Volumn 6, Issue 1, 2009, Pages 27-33

  Liu, Guoyan ^a   Liu, Shuxun ^a   Li, Ping ^a   Tang, Ling ^a   Han, Yanmei ^a   An, Huazhang ^a   Li, Jiangyan ^a   Dai, Xiankun ^a   Li, Nan ^a   Cao, Xuetao ^a   Yu, Yizhi ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Dendritic cell; Molecular cloning; Ubiquitin like protein

Indexed keywords

CELL PROTEIN; DENDRITIC CELL DERIVED UBIQUITIN LIKE PROTEIN; GLYCINE; ISOLEUCINE; LYSINE; POLYUBIQUITIN; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; DULP PROTEIN; PROTEASOME; UBIQUITIN; UBIQUITIN DOMAIN PROTEIN; DC UBP PROTEIN, HUMAN; DC-UBP PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN; CONTROLLED STUDY; CYTOSOL; DENDRITIC CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; UBIQUITINATION; ENZYME MECHANISM; MITOCHONDRIAL MEMBRANE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL NUCLEUS; CLONING, MOLECULAR; CYTOSOL; DENDRITIC CELLS; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; UBIQUITIN; UBIQUITINS;

EID: 65549105606     PISSN: 10078738     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.4     Document Type: Article

References (25)

1. Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene. 2000;248:1-14.
2. Raasi S, Schmidtke G, Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem. 2001;276:35334-35343.
3. Herrmann J, Lerman LO, Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ Res. 2007;100:1276-1291.
4. Schnell JD, Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem. 2003;278:35857-35860.
5. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002;82:373-428.
6. Kamitani T, Kito K, Nguyen HP, Yeh ET. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997;272:28557-28562.
7. Gong L, Kamitani T, Millas S, Yeh ET. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem. 2000;275:14212-14216.
8. Kamitani T, Kito K, Nguyen HP, Fukuda-Kamitani T, Yeh ET. Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem. 1998;273:11349-11353.
9. Smolen GA, Vassileva MT, Wells J, Matunis MJ, Haber DA. SUMO-1 modification of the Wilms' tumor suppressor WT1. Cancer Res. 2004;64:7846-7851.
10. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol. 2005;25:3483-3491.
11. Glockzin S, Ogi FX, Hengstermann A, Scheffner M, Blattner C. Involvement of the DNA repair protein hHR23 in p53 degradation. Mol Cell Biol. 2003;23:8960-8969.
12. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425-479.
13. Reinstein E. Immunologic aspects of protein degradation by the ubiquitin-proteasome system. Isr Med Assoc J. 2004;6:420-424.
14. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol.1991;9:271-296.
15. Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani, Yeh ET. Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem. 1998;273:3117-3120.
16. Vassileva MT, Matunis MJ. SUMO modification of heterogeneous nuclear ribonucleoproteins. Mol Cell Biol. 2004; 24:3623-3632.
17. Zhang H, Saitoh H, Matunis MJ. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell Biol. 2002;22:6498-6508.
18. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and essential for SUMO-1 modification. J Biol Chem. 2001;276:21664-21669.
19. Hicke L. A new ticket for entry into budding vesicles-ubiquitin. Cell. 2001;106:527-530.
20. Kamitani T, Nguyen HP, Yeh ET. Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem. 1997;272:14001-14004.
21. Dorval V, Fraser PE. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins Tau and α-Synuclein. J Biol Chem. 2006;281:9919-9924.
22. Watson IR, Blanch A, Lin DC, Ohh M, Irwin MS. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. J Biol Chem. 2006;281:34096-34103.
23. Hietakangas V, Anckar J, Blomster HA, et al. PDSM, A motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci U S A. 2006;103:45-50.
24. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 2004;18:2046-2059.
25. Matunis MJ, Wu J, Blobel G. SUMO-1 modification and its role in targeting the Ran GTPase-activating Protein, RanGAP1, to the nuclear pore complex. J Cell Biol. 1998;140:499-509.